-+ 0.00%
-+ 0.00%
-+ 0.00%
Syndax Pharmaceuticals, BioNTech, Seagate And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Share
Listen to the news

U.S. stock futures were mixed this morning, with the Dow futures gaining around 200 points on Tuesday.

Shares of Syndax Pharmaceuticals, Inc (NASDAQ:SNDX) fell sharply in pre-market trading after the company announced that the MAXPIRe Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis did not meet its primary endpoint of the annualized rate of decline in forced vital capacity.

Syndax Pharmaceuticals shares dipped 17.2% to $13.70 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

  • Zhibao Technology Inc. (NASDAQ:ZBAO) declined 16.7% to $2.00 in pre-market trading after falling 16% on Monday.
  • Chaince Digital Holdings Inc. (NASDAQ:CD) fell 10.8% to $6.41 in pre-market trading after dipping 17% on Monday.
  • Six Flags Entertainment Corp (NYSE:FUN) dipped 7.8% to $10.99 in pre-market trading.
  • SentinelOne Inc (NYSE:S) fell 7% to $23.86 in pre-market trading after the company announced a proposed private placement of $1.25 billion of convertible senior notes due 2031.
  • Western Digital Corp (NASDAQ:WDC) declined 6.1% to $363.41 in pre-market trading.
  • BioNTech SE – ADR (NASDAQ:BNTX) dipped 6.1% to $90.01 in pre-market trading after the company issued an update on Phase 2/3 clinical trial for mRNA cancer immunotherapy candidate BNT113 in metastatic HPV16-positive head and neck cancer.
  • SK Hynix Inc – ADR (NASDAQ:SKHY) fell 5.9% to $152.65 in pre-market trading after declining 4% on Monday.
  • Seagate Technology Holdings PLC (NASDAQ:STX) fell 5.7% to $710.10 in pre-market trading.
  • ChipMOS Technologies Inc – ADR (NASDAQ:IMOS) fell 4.2% to $72.00 in pre-market trading.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending